These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36174955)

  • 1. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
    Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
    J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.
    Guo X; Wang R; Chen R; Zhang Z; Wang J; Liu X
    Clin Chim Acta; 2024 Jun; 560():119732. PubMed ID: 38772522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
    Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
    Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global and targeted serum metabolic profiling of colorectal cancer progression.
    Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
    Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive Lipid Characteristics of Colorectal Cancer Revealed through Non-targeted Lipidomics Analysis of Tongue Coating.
    Chen Q; Lin F; Li W; Gu X; Chen Y; Su H; Zhang L; Zheng W; Zeng X; Lu X; Wang C; Chen W; Zhang B; Zhang H; Gong M
    J Proteome Res; 2024 Jun; 23(6):2054-2066. PubMed ID: 38775738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence.
    Li G; Zhao D; Peng X; Zhao Y
    Gene; 2024 Feb; 894():147955. PubMed ID: 37925119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
    Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
    Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CBX2 Expression in Colorectal Mucosa-adenoma-adenocarcinoma Sequence.
    Wang B; Huang M; Wang X; Tseng Y; Luo F; Liu J
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1051-1056. PubMed ID: 34500520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of dimethylated nucleosides in serum from colorectal cancer patients by hydrophilic interaction liquid chromatography-tandem mass spectrometry.
    Cao X; Wang M; Huang Y; Zhang M; Zheng F; Zhang G; Su J; Yuan Y; Guo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123973. PubMed ID: 38142502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli strains of phylogenetic group B2 and D and bacteriocin production are associated with advanced colorectal neoplasia.
    Kohoutova D; Smajs D; Moravkova P; Cyrany J; Moravkova M; Forstlova M; Cihak M; Rejchrt S; Bures J
    BMC Infect Dis; 2014 Dec; 14():733. PubMed ID: 25540872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
    Igder S; Mohammadiasl J; Mokarram P
    Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
    Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
    Cancer Metab; 2016; 4():11. PubMed ID: 27275383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men.
    Yagi M; Sasaki Y; Abe Y; Yaoita T; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kon T; Nishise S; Ueno Y
    Digestion; 2020; 101(5):571-578. PubMed ID: 31269491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.